Clinical Trial Update: COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)

View source ↗

Summary

Clinical trial update noting that the study on COVID-19 associated pulmonary aspergillosis and other invasive fungal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Pulmonary Aspergillosis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Covid19, Aspergillosis | Status: COMPLETED